2026· Iranian Journal of Basic Medical Sciences· Vol 29, pp. 1648 - 1658· 0 citations· 26 references
Medicine
TL;DR
NPCM11 and MPCM11 were promising formulations of CM11 for treating P. aeruginosa infections and MTT assay revealed that NPCM11 and MPCM11 significantly reduced CM11 cytotoxicity.
Abstract
Objective(s): Pseudomonas aeruginosa (P. aeruginosa) is a Gram-negative bacterium capable of causing acute and chronic infections. Treating these infections is increasingly challenging as this bacterium develops antibiotic resistance. Antimicrobial peptides (AMPs) have emerged as promising therapeutic candidates due to their broad-spectrum activity. Cecropin-Melittin-11 (CM11), a cationic AMP, has shown antimicrobial activity against various pathogens. However, the progression of AMPs from preclinical research to clinical application is hindered by enzymatic degradation, short systemic half-life, and cytotoxicity. To overcome these challenges, poly(lactic-co-glycolic acid)(PLGA) particles for peptide delivery have gained attention. Materials and Methods: CM11-loaded PLGA nanoparticles (NPCM11) and microparticles (MPCM11) were prepared using a double-emulsion solvent evaporation (W1/O/W2) method and characterized for particle size, morphology, encapsulation efficiency, and in vitro release. Their antibacterial activity against planktonic and biofilm-forming P. aeruginosa was evaluated using broth microdilution assay. Their cytocompatibility was evaluated using 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) assay. Results: Optimum formulations of NPCM11 and MPCM11 were synthesized, exhibiting spherical morphology with average sizes of 281 nm and 7.63 µm, respectively. The encapsulation efficiency (EE%) of NPCM11 and MPCM11 was 63.5% and 60.3%, respectively, while the in vitro CM11 release was 82% and 58%. According to broth microdilution and biofilm inhibition assays, NPCM11 outperformed free CM11 and MPCM11 against planktonic bacteria, whereas both NPCM11 and MPCM11 were superior to free CM11 in biofilm inhibition. MTT assay revealed that NPCM11 and MPCM11 significantly reduced CM11 cytotoxicity. Conclusion: Overall, NPCM11 and MPCM11 were promising formulations of CM11 for treating P. aeruginosa infections.
Enhanced therapeutic potential for scorpion-derived AMP analogs-loaded PLGA nanoparticles is demonstrated, providing a dual antimicrobial and anti-inflammatory strategy for severe infections such as sepsis, and support further development of AMP-based nanomedicines.
Bruno Amorim-Carmo, Emanuell Santos-Silva, Alessandra Daniele-Silva et al.· Biomedicine & pharmacotherap...· 0 citations
This study identified potent AMPs with promising therapeutic potential by constructing and screening a synthetic random peptide library using a bacterial surface display system, and identified WP-4 and WP-6, which showed high antimicrobial activity, good biocompatibility, rapid bactericidal effects, and low propensity...
Shuai-Yang Wang, Shuang Wang, Xiu-Jian Liu et al.· Journal of Medicinal Chemist...· 0 citations
Background/Objectives: Ciprofloxacin (CIP) is a fluoroquinolone extensively used in hospital settings for the treatment of bacterial infections; however, this antibiotic requires multiple doses because it has poor absorption, rapid elimination, and is ineffective against resistant bacterial strains. Enhanced delivery e...
Recently, Staphylococcus aureus and Pseudomonas aeruginosa have become multidrug-resistant (MDR) and produce many virulence factors, posing a health risk. Therefore, addressing knowledge gaps and finding solutions to the challenge caused by bacteria's increased resistance to multiple antibiotics is an urgent need. To a...
Nibras Saleh Ghafel Al Tameemi, I. Abdul-Husin, Raid Razzaq Ojaimi et al.· Hayati Journal of Bioscience...· 0 citations
The multifunctional nature of the nanoassemblies highlights their potential for combining antimicrobial, radical-scavenging and anti-inflammatory properties, offering a promising approach to addressing the complex challenges associated with bacterial infections, including those involving biofilms.
Loredana Ferreri, Lucia Cambria, G. Ginestra et al.· International journal of pha...· 0 citations
Multidrug-resistant (MDR) bacteria pose a significant global health threat, limiting therapeutic options and increasing morbidity, mortality, and healthcare costs. To address this challenge, combinations of natural compounds with existing antibiotics encapsulated in nanostructured lipid carriers (NLCs), are increasingl...
A. A. Abdulkareem, Zainab Lafi, Hala Al-Daghistani· BioNanoScience· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.